WallStreetZenWallStreetZen

NASDAQ: ELYM
Eliem Therapeutics Inc Stock Ownership - Who owns Eliem Therapeutics?

Insider buying vs selling

Have Eliem Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Valerie MorissetEVP RD AND CSO2023-09-205,431$0.00
$10.86Buy

1 of 1

ELYM insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ELYM insiders and whales buy or sell their stock.

ELYM Shareholders

What type of owners hold Eliem Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Ra Capital Management LP45.21%13,150,849$113.89MInstitution
Ai Eti LLC17.22%5,009,400$43.38MInsider
Bml Capital Management LLC7.54%2,193,742$19.00MInstitution
Ra Capital Management LP2.89%841,087$7.28MInsider
Driehaus Capital Management LLC2.79%811,680$7.03MInstitution
Valerie Morisset1.74%505,307$4.38MInsider
Vanguard Group Inc1.07%310,486$2.69MInstitution
Adam Joseph Rosenberg0.61%178,100$1.54MInsider
Atom Investors LP0.27%78,276$677.87kInstitution
Geode Capital Management LLC0.23%66,626$576.98kInstitution

1 of 3

ELYM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ELYM57.94%22.46%Net Buying
ATNM17.68%82.32%
MGX33.76%32.96%Net Buying
EPIX73.24%26.76%Net BuyingNet Buying
QTTB26.61%73.39%Net SellingNet Selling

Eliem Therapeutics Stock Ownership FAQ

Who owns Eliem Therapeutics?

Eliem Therapeutics (NASDAQ: ELYM) is owned by 57.94% institutional shareholders, 22.46% Eliem Therapeutics insiders, and 19.60% retail investors. Ai Eti LLC is the largest individual Eliem Therapeutics shareholder, owning 5.01M shares representing 17.22% of the company. Ai Eti LLC's Eliem Therapeutics shares are currently valued at $41.53M.

If you're new to stock investing, here's how to buy Eliem Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.